Received Apr 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (OTHER) | UNKNOWN MANUFACTURER | UNK | — | IM / UN |
| UNK | VACCINE NOT SPECIFIED (OTHER) | UNKNOWN MANUFACTURER | UNK | — | IM / UN |
Guillain Barre syndrome, onset 4/3/25
none
none
estradiol, progesterone, cetirizine
vicodin
CSF 1 WBC, 91 RBC, neurological assessment by myself with exam and clinical history consistent with AIDP-- progressive sensory loss in legs, progressive weakness in both legs, areflexia on examination, unable to ambulate.